Sravan Emany

Sravan Kumar Emany currently works at Spembly Medical Ltd., as Director from 2019, Integra NeuroSciences Ltd., as Director from 2019, Kyverna Therapeutics, Inc., as Independent Director from 2026, Integra LS (Benelux) NV, as Director from 2019, Caveangle Ltd., as Director from 2019, Integra NeuroSciences Holdings (UK) Ltd., as Director from 2019, and Beam Therapeutics, Inc., as Chief Financial Officer from 2024.
Mr. Emany also formerly worked at Bank of America Corp., as Managing Director from 2008 to 2018, Merrill Lynch, Pierce, Fenner & Smith, Inc., as Managing Director-Mergers & Acquisitions from 2008 to 2018, BofA Securities, Inc., as Managing Director-Mergers & Acquisitions Group from 2008 to 2018, VectivBio Holding AG, as Director, Assertio Holdings, Inc., as Independent Director from 2023 to 2026, Integra LifeSciences Holdings Corp., as Chief Strategy Officer & VP-Commercial Excellence from 2020 to 2021, and Ironwood Pharmaceuticals, Inc., as Senior VP, Chief Financial & Operating Officer in 2024.
Mr. Emany received his undergraduate degree from The Johns Hopkins University and graduate degree from The Paul H.
Nitze School of Advanced International Studies.